A07AA09 - Vancomycin |
Probably not porphyrinogenic |
PNP |
Rationale
Glycopeptide. Probably insignificant systemic exposure. Three references consider it safe.
Chemical description
Tricyclic glycopeptide antibiotic used in enterocolitis caused by Clostridium Difficile. Given perorally in a daily dose of 500mg for 10-14 days. Only minute amounts are absorbed.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| 1. | Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
|
9074793 |
| Porphyria Drug Lists | ||
| 2. | Michael Moore's List
No longer maintained
|
|
| 3. | French List
Centre Français des Porphyries
|
|
| 4. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames
Vancocin · Vancomycine 
Vangozyr 
Vankomicin 
Levovanox · Maxivanil 
Cedepos · Levovanox · Vancocin 
Vancocin · Vancomycin 
Vancocin Matrigel · Vancomycin 
Vancocin · Vancomycin · Vancomycine 
Vancocin · Vancomycin 
Vancomycin · Vankomycin 
Vancomycin 
Difforal · Vancover 
Vancocin · Vancomycin 
Vancomycin 
Vancomycin 
Vancomycin 
Vancosala · Vanocin 
Vankomicin 
Edicin · Vancocin · Vancomycin · Vankomicin · Vankomicinijev 
Cedepos